Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly

Age is one of the strongest predictors of cardiovascular disease (CVD) risk. Treatment with statins can significantly reduce CVD events and mortality in both primary and secondary prevention. Yet despite the high CVD risk among the elderly, there is underutilization of statins in this population (ie...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Sydney B, Blaha, Michael J, Blumenthal, Roger S, Michos, Erin D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066250/
https://www.ncbi.nlm.nih.gov/pubmed/21472089
http://dx.doi.org/10.2147/CIA.S8101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066250/
https://www.ncbi.nlm.nih.gov/pubmed/21472089
http://dx.doi.org/10.2147/CIA.S8101

Ejemplares similares